All In Biotech

Drug Trial Radar · NCT06975514

Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

A Randomized, Double-blind, Active-controlled, Parallel-group Clinical Study to Evaluate the Efficacy and Safety of YZJ-1139 Tablets in the Treatment of Insomnia Disorder

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

61

Actual

Start

Mar 25, 2025

Primary completion

Jul 21, 2025

Study completion Aug 14, 2025

Sponsor

Sponsor type
Industry
First posted
May 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess efficacy of YZJ-1139 for 28 days in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.

Conditions

  • Insomnia Disorder

Interventions

  • YZJ-1139Drug

    YZJ-1139 20mg tablets, once daily in the evening

  • ZolpidemDrug

    Zolpidem 10mg tablets, once daily in the evening

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline of Mean Objective Wake After Sleep Onset (WASO)Time frame: Baseline, Day 1/Day 2, Day 27/Day 28
  2. Change from baseline of Mean Objective Sleep Efficiency (SE)Time frame: Baseline, Day 1/Day 2, Day 27/Day 28
  3. Change from baseline of Mean Objective Total Sleep Time (TST)Time frame: Baseline, Day 1/Day 2, Day 27/Day 28
  4. Change from baseline of Mean Objective Latency to Persistent Sleep (LPS)Time frame: Baseline, Day 1/Day 2, Day 27/Day 28

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Peking University People's Hospital

    Beijing, China

  • ChengDu Second People's Hospital

    Chengdu, China

  • ChongQing Traditional Chinese Medicine Hospital

    Chongqing, China

  • Deyang People's Hospital

    Deyang, China

  • The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital)

    Guangzhou, China

  • The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)

    Jinan, China

  • The Second Affiliated Hospital Of NanChang University

    Nanchang, China

  • The First Affiliated Hospital of Ningbo University

    Ningbo, China

  • ShengJing Hospital Of China Medical University

    Shenyang, China

  • The Third Hospital of Hebei Medical University

    Shijiazhuang, China

  • SuZhou GuangJi Hospital

    Suzhou, China

  • The Second Affiliated Hospital of Soochow University

    Suzhou, China

  • Tianjin Anding Hospital

    Tianjin, China

  • Wuhan No.1 Hospital

    Wuhan, China

  • Yan'an University Xianyang Hospital

    Yan’an, China

  • The Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.